Government ❯ Health ❯ Healthcare

Regulations

Product Safety Cannabis FDA Cosmetic Safety Food Safety Drug Advertising Cosmetics Pharmaceuticals National Pharmaceutical Pricing Authority Chronic Conditions

Anvisa Keeps Ypê Product Lots Suspended After Factory Quality Failures

The regulator limited the return to market to newer lots following lab reports that showed compliance with Brazil's sanitary rules.

ANMAT Bans Unregistered Children's Cosmetics and Falsified Medicines Nationwide

Federal Agencies Reshape No Surprises Act IDR With Lower Fees and Wider Batching

Tamil Nadu Flags Off 40 Vehicles to Strengthen Medical Oversight

ANMAT Bans Children’s Cosmetics Lacking Health Registration Nationwide

Brazil's Anvisa Orders Recall of Five Impala Gel Nail Polish Lines

ANMAT Bans Unregistered Hair Treatments and Dental Suture Nationwide Over Safety Risks

ANMAT Pulls Dozens of Unregistered Cosmetics, Hair Products and Perfumes From Argentina’s Market

ANMAT Expands Nationwide Bans to Unregistered Hair Lines, Mentisan Ointment and Antifungal Spray

Anvisa Unveils Draft to Authorize Domestic Medicinal Cannabis Cultivation Ahead of March 31 Deadline

Anvisa Bans 30 Landerlan Anabolic Products Over Lack of Registration

ANMAT Widens Nationwide Bans to Unregistered Soaps and High‑Risk Medical Devices

Sindh Caps Prices for Dengue, Malaria and CBC Tests Through December 31

FDA Escalates Crackdown on Drug Ads, Moves to Close ‘Adequate Provision’ Loophole

FDA to Publicly Release All Future Drug Rejection Letters, Posts 89 Recent CRLs

India Fixes Ceiling Prices for 37 Essential and Four Emergency Medicines

ANMAT Extends Nationwide Bans to Hair-Care Lines and Influencer-Promoted Dental Products

Telangana, Andhra Pradesh Intensify Inspections of Fertility Clinics After Surrogacy Fraud

ANMAT Bans Olive Oils, Sugar, Cannabis Ointment and Medical Devices Nationwide

FDA and A.P. Deauville Recall Over 67,000 Cases of Power Stick Roll-On Deodorant